Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
Cancer Cell · 2024-11 · 42 (11) · 1882-1897.e7
DOI: 10.1016/j.ccell.2024.09.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2024-11. Verfasst von Minjie Fu und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China; National Center for Neurological Di…. Hauptthemen laut MEDLINE: Brain Neoplasms, Lung Neoplasms, Drug Resistance, Neoplasm, Protein Kinase Inhibitors. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Science and Technology Infrastructure Program, Natural Science Foundation of Shanghai Municipality, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China; National Center for Neurological Disorders, Shanghai 200040, China; Shanghai Key Laboratory of Brain Func…
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China; Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers C…
- Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, Fudan Uni…
- Department of General Surgery, Jing'an District Central Hospital of Shanghai, Huashan Hospital, Fudan University, Shanghai 200042, China.
- Shanghai Institute for Advanced Immunochemical Studies (SIAIS), Shanghai Tech University, Shanghai 201210, China.
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China; Institutes of Biomedical Sciences, Shanghai Medical College of Fudan University, Shanghai 200032, China.
Förderung
- National Science and Technology Infrastructure Program
- Natural Science Foundation of Shanghai Municipality
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- National Key Research and Development Program of China
- Shanghai Municipal Hospital Development Center
- Ministry of Science and Technology of the People's Republic of China
- Fudan University
- Chinese Academy of Meteorological Sciences
Zitieren
APA
Fu, M., Zhao, J., Zhang, L., Sheng, Z., Li, X., Qiu, F., Feng, Y., You, M., Xu, H., Zhang, J., Zeng, R., Huang, Y., Li, C., Chen, W., Chen, Z., Peng, H., Li, L., Wu, Y., Ye, D., …, & Mao, Y. (2024). Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade. Cancer Cell, 42(11), 1882-1897.e7. https://doi.org/10.1016/j.ccell.2024.09.012
Vancouver
Fu M, Zhao J, Zhang L, Sheng Z, Li X, Qiu F, et al. Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade. Cancer Cell. 2024;42(11):1882-1897.e7. doi:10.1016/j.ccell.2024.09.012
BibTeX
@article{Fu2024,
author = {Fu, Minjie and Zhao, Jiaxu and Zhang, Licheng and Sheng, Zhewei and Li, Xiaohui and Qiu, Fufang and Feng, Yuan and You, Muyuan and Xu, Hao and Zhang, Jinsen and Zeng, Rui and Huang, Yang and Li, Cheng and Chen, Wenhan and Chen, Zheng and Peng, Haibao and Li, Longzhi and Wu, Yonghe and Ye, Dan and Chi, Yudan and Hua, Wei and Mao, Ying},
title = {Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade},
journal = {Cancer Cell},
year = {2024},
volume = {42},
number = {11},
pages = {1882--1897.e7},
doi = {10.1016/j.ccell.2024.09.012}
}
EUVIMED